These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 108388)

  • 21. [Current possibilities in the therapy of iron overload].
    Cermák J
    Vnitr Lek; 1994 Sep; 40(9):605-8. PubMed ID: 7975366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemosiderosis in rodents and the effect of acetohydroxamic acid on urinary iron excretion.
    Corden BJ
    Exp Hematol; 1986 Nov; 14(10):971-4. PubMed ID: 3770104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The mechanism and specificity of iron transport in Rhodotorula pilimanae probed by synthetic analogs of rhodotorulic acid.
    Müller G; Barclay SJ; Raymond KN
    J Biol Chem; 1985 Nov; 260(26):13916-20. PubMed ID: 4055765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical management of thalassemia. The status of new iron chelators.
    Cerami A; Grady RW; Peterson CM; Bhargava KK
    Ann N Y Acad Sci; 1980; 344():425-35. PubMed ID: 6446872
    [No Abstract]   [Full Text] [Related]  

  • 25. Rhodotorulic acid production by Rhodotorula mucilaginosa.
    Andersen D; Renshaw JC; Wiebe MG
    Mycol Res; 2003 Aug; 107(Pt 8):949-56. PubMed ID: 14531617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rhodotorulic acid from species of Leucosporidium, Rhodosporidium, Rhodotorula, Sporidiobolus, and Sporobolomyces, and a new alanine-containing ferrichrome from Cryptococcus melibiosum.
    Atkin CL; Neilands JB; Phaff HJ
    J Bacteriol; 1970 Sep; 103(3):722-33. PubMed ID: 5529038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A hydroxamic acid present in Rhodotorula pilimanae cultures grown at low pH and its metabolic relation to rhodotorulic acid.
    Akers HA; Neilands JB
    Biochemistry; 1973 Feb; 12(5):1006-10. PubMed ID: 4686797
    [No Abstract]   [Full Text] [Related]  

  • 28. The use of chang cells cultured in vitro to evaluate potential iron chelating drugs.
    White GP; Jacobs A; Grady RW; Cerami A
    Br J Haematol; 1976 Aug; 33(4):487-95. PubMed ID: 1009021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biosynthesis of sideramines in fungi. Rhodotorulic acid synthetase from extracts of rhodotorula glutinis.
    Anke T; Diekmann H
    FEBS Lett; 1972 Nov; 27(2):259-62. PubMed ID: 4677112
    [No Abstract]   [Full Text] [Related]  

  • 30. Stereospecificity of siderophore-mediated iron uptake in Rhodotorula pilimanae as probed by enantiorhodotorulic acid and isomers of chromic rhodotorulate.
    Müller G; Isowa Y; Raymond KN
    J Biol Chem; 1985 Nov; 260(26):13921-6. PubMed ID: 4055766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of Naegleria fowleri by microbial iron-chelating agents: ecological implications.
    Newsome AL; Wilhelm WE
    Appl Environ Microbiol; 1983 Feb; 45(2):665-8. PubMed ID: 6830222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biliary iron excretion in normal and iron-loaded rats after desferrioxamine and CaDTPA.
    Figueroa WG; Thompson JH
    Am J Physiol; 1968 Oct; 215(4):807-10. PubMed ID: 5676381
    [No Abstract]   [Full Text] [Related]  

  • 33. [HEMOCHROMATOSIS--A CASE TREATED WITH DESFERRIOXAMINE].
    GYLLENSWAERD A; ESTBORN B
    Sven Lakartidn; 1963 Nov; 60():3506-10. PubMed ID: 14096236
    [No Abstract]   [Full Text] [Related]  

  • 34. Rhodotorulic acid, a diketopiperazine dihydroxamic acid with growth-factor activity. I. Isolation and characterization.
    Atkin CL; Neilands JB
    Biochemistry; 1968 Oct; 7(10):3734-9. PubMed ID: 4971459
    [No Abstract]   [Full Text] [Related]  

  • 35. Influence of desferrioxamine on the renal excretion of iron. Preliminary report.
    NIELSEN JB
    Acta Med Scand; 1963 Apr; 173():499-504. PubMed ID: 13938509
    [No Abstract]   [Full Text] [Related]  

  • 36. [PRELIMINARY RESULTS ON THE USE OF DESFERRIOXAMINE IN POLYCYTHEMIA].
    BETETTO D; CRISTINA P; CAPPELLETTI S
    Haematologica; 1963; 48():497-507. PubMed ID: 14123802
    [No Abstract]   [Full Text] [Related]  

  • 37. [EFFECT OF DESFERRIOXAMINE ON ERYTHROPOIESIS].
    KELLER HM
    Schweiz Med Wochenschr; 1963 Oct; 93():1511-2. PubMed ID: 14093399
    [No Abstract]   [Full Text] [Related]  

  • 38. Drug Selection and Posology, Optimal Therapies and Risk/Benefit Assessment in Medicine: The Paradigm of Iron-Chelating Drugs.
    Kontoghiorghes GJ
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biosynthesis Pathways, Transport Mechanisms and Biotechnological Applications of Fungal Siderophores.
    Pecoraro L; Wang X; Shah D; Song X; Kumar V; Shakoor A; Tripathi K; Ramteke PW; Rani R
    J Fungi (Basel); 2021 Dec; 8(1):. PubMed ID: 35049961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Present status and future prospects of oral iron chelation therapy in thalassaemia and other diseases.
    Kontoghiorghes GJ
    Indian J Pediatr; 1993; 60(4):485-507. PubMed ID: 8262586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.